Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares PR Newswire - Fri Jun 19, 7:00AM CDT

BOSTON and ROLLE, Switzerland , June 19, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the closing of its previously announced...

SOPH : 5.46 (+4.20%)
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares PR Newswire - Tue Jun 16, 8:21PM CDT

BOSTON and ROLLE, Switzerland , June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced...

SOPH : 5.46 (+4.20%)
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares PR Newswire - Tue Jun 16, 3:20PM CDT

BOSTON and ROLLE, Switzerland , June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the commencement of a proposed underwritten...

SOPH : 5.46 (+4.20%)
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting PR Newswire - Wed Jun 10, 7:00AM CDT

Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board

SOPH : 5.46 (+4.20%)
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center PR Newswire - Thu Jun 4, 7:00AM CDT

SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology

SOPH : 5.46 (+4.20%)
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. PR Newswire - Wed May 13, 4:00AM CDT

LONDON , May 13, 2026 /CNW/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, one of England's leading pathology providers,...

SOPH : 5.46 (+4.20%)
SOPHiA GENETICS Reports First Quarter 2026 Results PR Newswire - Tue May 5, 5:45AM CDT

BOSTON and ROLLE, Switzerland , May 5, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today reported financial results for the first quarter...

SOPH : 5.46 (+4.20%)
SOPHiA GENETICS: Whether Platform Economics or Customer Concentration Wins the Narrative Barchart - Mon May 4, 4:29PM CDT

Barchart Research What to Expect from SOPH Earnings SOPH Generated May 4, 2026 Current Price $5.30 Consensus Rating Strong Buy Average Move 5.33% SOPHiA GENETICS: Whether Platform Economics or Customer...

SOPH : 5.46 (+4.20%)
SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026 PR Newswire - Tue Apr 21, 7:00AM CDT

BOSTON and ROLLE, Switzerland , April 21, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results...

SOPH : 5.46 (+4.20%)
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 PR Newswire - Thu Apr 16, 7:00AM CDT

SAN DIEGO and NEW YORK , April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of...

SOPH : 5.46 (+4.20%)

Barchart Exclusives

Microsoft vs. Nvidia: Which AI Giant Is the Better Dividend Stock for the Long Haul? Barchart - Fri Jun 19, 6:00PM CDT
Microsoft and NVIDIA are AI giants, but which stock is the better buy? Compare growth, valuation, dividends, and Wall Street ratings. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.